Wedbush Securities Inc Affimed N.V. Transaction History

Wedbush Securities Inc

  • $2.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 01, 2019
SELL
$2.6 - $4.21 $28,600 - $46,310
-11,000 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$1.45 - $6.15 $15,950 - $67,650
11,000 New
11,000 $48,000
Q1 2018

May 01, 2018
SELL
$1.25 - $2.65 $15,000 - $31,800
-12,000 Closed
0 $0
Q4 2017

Feb 09, 2018
BUY
$1.23 - $2.3 $14,760 - $27,599
12,000
12,000 $16,000

Others Institutions Holding AFMD

# of Institutions
3
Shares Held
1.09M
Call Options Held
0
Put Options Held
0
View Full List

About Affimed N.V.

AFMD Quotes by TradingView
  • Ticker AFMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,339,008
  • Market Cap $185M
  • Description
  • Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...
More about AFMD
Track This Portfolio

Track Wedbush Securities Inc Portfolio

Follow Wedbush Securities Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email